Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes.
<h4>Background</h4>Atypical antipsychotic medications are widely prescribed for the adjunctive treatment of depression, yet their total risk-benefit profile is not well understood. We thus conducted a systematic review of the efficacy and safety profiles of atypical antipsychotic medicat...
Guardado en:
Autores principales: | Glen I Spielmans, Margit I Berman, Eftihia Linardatos, Nicholas Z Rosenlicht, Angela Perry, Alexander C Tsai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ffe1f0191a34caca1e30bed0cee47d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir S, et al.
Publicado: (2016) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan SX, et al.
Publicado: (2018) -
Atypical depression: current perspectives
por: Łojko D, et al.
Publicado: (2017) -
Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka M, et al.
Publicado: (2015) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
por: Gabriel A
Publicado: (2013)